Acorn Capital Advisors, LLC Bio Atla, Inc. Transaction History
Acorn Capital Advisors, LLC
- $144 Billion
- Q1 2025
A detailed history of Acorn Capital Advisors, LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Acorn Capital Advisors, LLC holds 4,032,046 shares of BCAB stock, worth $1.53 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
4,032,046
Previous 4,032,046
-0.0%
Holding current value
$1.53 Million
Previous $2.38 Billion
40.8%
% of portfolio
0.98%
Previous 1.25%
Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
46Shares Held
13.9MCall Options Held
20.3KPut Options Held
1.2K-
Vanguard Group Inc Valley Forge, PA1.82MShares$690,8400.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.69MShares$642,2410.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$522,1480.03% of portfolio
-
Black Rock Inc. New York, NY792KShares$300,7920.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny745KShares$283,0360.0% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $13.8M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...